Login to Your Account



BTG Raises $160M to Fund Nordion, Ekos Acquisitions

By Cormac Sheridan
Staff Writer

Friday, May 24, 2013
BTG plc grossed £106.3 million (US$160.2 million) in an accelerated book build in order to fund the acquisition of two businesses: the targeted therapies division of Nordion Inc. and Ekos Corp.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription